Loading...
•
Jan 31, 2024
HealthEquity Q4 2024 Earnings Report
HealthEquity's Q4 2024 financial performance was marked by revenue growth and increased profitability.
Key Takeaways
HealthEquity reported a 12% increase in revenue to $262.4 million for Q4 2024, with net income reaching $26.4 million and non-GAAP net income at $55.0 million. The company's adjusted EBITDA grew by 34% to $98.8 million, reflecting improved operational efficiency. They also delivered fiscal 2024 with a record of nearly $1 billion in revenue as well as over 500 bps expansion in Adjusted EBITDA margin.
Revenue increased by 12% year-over-year, reaching $262.4 million.
Net income was $26.4 million, a significant improvement from the net loss in Q4 FY23.
Non-GAAP net income rose to $55.0 million, compared to $31.3 million in the prior year.
Adjusted EBITDA increased by 34% to $98.8 million.
Revenue by Segment
Forward Guidance
For the fiscal year ending January 31, 2025, HealthEquity anticipates revenues between $1.14 billion and $1.16 billion. Net income is projected to be between $73 million and $88 million, with a non-GAAP net income outlook of $247 million to $262 million. Adjusted EBITDA is expected to range from $438 million to $458 million.
Positive Outlook
- Revenue is projected to be between $1.14 billion and $1.16 billion.
- Net income is expected to be between $73 million and $88 million.
- Non-GAAP net income is forecasted to be between $247 million and $262 million.
- Adjusted EBITDA is anticipated to be between $438 million and $458 million.
- Increases of approximately 15% in revenue and 20% in Adjusted EBITDA.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...